Latest filing published 03 Feb 2023 for TransMedics Group, Inc., €20k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of John F. Carey in TransMedics Group, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 3 May 2021 to 1 February 2023, the count stands at 23 filings.
The open-market record consists of 1 sale worth €49k, with no purchase. Other entries cover 22 option exercises.
Most recently, on 3 February 2023, the filings show an option exercise worth €20k in TransMedics Group, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations